{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T22:47:52Z","timestamp":1782514072348,"version":"3.54.5"},"reference-count":32,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2022,11,7]],"date-time":"2022-11-07T00:00:00Z","timestamp":1667779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1176131"],"award-info":[{"award-number":["1176131"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["2008276"],"award-info":[{"award-number":["2008276"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Health and Medical Research Council Investigator Grant","award":["1176131"],"award-info":[{"award-number":["1176131"]}]},{"name":"National Health and Medical Research Council Investigator Grant","award":["2008276"],"award-info":[{"award-number":["2008276"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Background: New technologies and therapies allow the possibility of a single-visit test and treat model for hepatitis C virus (HCV), addressing some of the barriers to care faced by people who inject drugs. Methods: The TEMPO Pilot Study was an interventional cohort study evaluating a single-visit test and treat intervention among people with recent injecting drug use at a one peer-led needle and syringe program (NSP) in Sydney, Australia between September 2019 and February 2021. This analysis evaluated awareness of HCV status and agreement of self-report with HCV RNA test results. The analysis also assessed acceptability of: modality of result delivery, modality of blood sampling, site of treatment, and duration of treatment. Results: Among 101 participants (median age 43; 31% female), 100 had a valid HCV RNA test result and 27% (27\/100) were HCV RNA detectable. Overall, 65% (65\/100) were aware of their status. Among people with a positive HCV RNA result, 48% (13\/27) were aware of their status. People preferred same-day HCV test results (95%, 96\/101), and preferred to receive results in person (69%, 70\/101). Receiving treatment at an NSP was acceptable (100%, 101\/101) and 78% (79\/101) were willing to discuss their health with a peer NSP worker. Conclusion: Half of people with current HCV infection were aware of their status. The high acceptability of simplified testing and treatment pathways delivered at NSPs indicates that this is an appropriate strategy to improve HCV awareness and treatment uptake in this population.<\/jats:p>","DOI":"10.3390\/v14112463","type":"journal-article","created":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T10:55:32Z","timestamp":1667904932000},"page":"2463","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Awareness of HCV Status and Preferences for Testing and Treatment among People with Recent Injecting Drug Use at a Peer-Led Needle and Syringe Program: The TEMPO Pilot Study"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9082-9714","authenticated-orcid":false,"given":"Anna","family":"Conway","sequence":"first","affiliation":[{"name":"The Kirby Institute, UNSW Sydney, Sydney 2052, Australia"},{"name":"Centre for Social Research in Health, UNSW Sydney, Sydney 2052, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip","family":"Read","sequence":"additional","affiliation":[{"name":"The Kirby Institute, UNSW Sydney, Sydney 2052, Australia"},{"name":"Kirketon Road Centre, South Eastern Sydney Local Health District, Sydney 2010, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosie","family":"Gilliver","sequence":"additional","affiliation":[{"name":"Kirketon Road Centre, South Eastern Sydney Local Health District, Sydney 2010, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony","family":"McNaughton","sequence":"additional","affiliation":[{"name":"NSW Users and AIDS Association, Sydney 2010, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Valerio","sequence":"additional","affiliation":[{"name":"The Kirby Institute, UNSW Sydney, Sydney 2052, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan","family":"Cunningham","sequence":"additional","affiliation":[{"name":"The Kirby Institute, UNSW Sydney, Sydney 2052, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Henderson","sequence":"additional","affiliation":[{"name":"NSW Users and AIDS Association, Sydney 2010, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett","family":"Hadlow","sequence":"additional","affiliation":[{"name":"Kirketon Road Centre, South Eastern Sydney Local Health District, Sydney 2010, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrina","family":"Molloy","sequence":"additional","affiliation":[{"name":"Kirketon Road Centre, South Eastern Sydney Local Health District, Sydney 2010, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Doab","sequence":"additional","affiliation":[{"name":"Kirketon Road Centre, South Eastern Sydney Local Health District, Sydney 2010, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shane","family":"Tillakeratne","sequence":"additional","affiliation":[{"name":"The Kirby Institute, UNSW Sydney, Sydney 2052, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Pepolim","sequence":"additional","affiliation":[{"name":"NSW Users and AIDS Association, Sydney 2010, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Harrod","sequence":"additional","affiliation":[{"name":"NSW Users and AIDS Association, Sydney 2010, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Dore","sequence":"additional","affiliation":[{"name":"The Kirby Institute, UNSW Sydney, Sydney 2052, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1833-2017","authenticated-orcid":false,"given":"Jason","family":"Grebely","sequence":"additional","affiliation":[{"name":"The Kirby Institute, UNSW Sydney, Sydney 2052, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,11,7]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (2016). Global Health Sector Strategy on Viral Hepatitis 2016\u20132021: Towards Ending Viral Hepatitis, World Health Organization."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1111\/jvh.13399","article-title":"Loss to follow-up in the hepatitis C care cascade: A substantial problem but opportunity for micro-elimination","volume":"27","author":"Drenth","year":"2020","journal-title":"J. Viral Hepat."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Alimohammadi, A., Holeksa, J., Thiam, A., Truong, D., and Conway, B. (2018). Real-world Efficacy of Direct-Acting Antiviral Therapy for HCV Infection Affecting People Who Inject Drugs Delivered in a Multidisciplinary Setting. Open Forum Infect. Dis., 5.","DOI":"10.1093\/ofid\/ofy120"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1046\/j.1360-0443.2002.00208.x","article-title":"The association between knowledge of hepatitis C virus status and risk behaviors in injection drug users","volume":"97","author":"Kwiatkowski","year":"2002","journal-title":"Addiction"},{"key":"ref_5","unstructured":"Grebely, J., Gilliver, R., McNaughton, T., Henderson, C., Hadlow, B., Molloy, K., Tillakeratne, S., Pepolim, L., Harrod, M.E., and Dore, G.J. (2021, January 13\u201315). Point-of-care HCV RNA testing, linkage to nursing care, and peer-supported engagement and delivery to enhance HCV treatment among people with recent injecting drug use at a community-led needle and syringe program: The TEMPO pilot study. Proceedings of the International Network on Health and Hepatitis in Substance Users Conference, Virtual."},{"key":"ref_6","unstructured":"O\u2019Loan, J., Young, M., Mooney, M., and O\u2019Flynn, M. (2021, January 13\u201315). Same day delivery! HCV point of care testing in South East Queensland marginalised communities simplifies diagnosis and ensures rapid access to treatment. Proceedings of the International Conference on Hepatitis Care in Substance Users, Virtual."},{"key":"ref_7","unstructured":"Ralton, L., McCartney, E.M., Ferguson, C., Dawe, J., Richmond, J., Tse, E., Wigg, A., Cock, V., Rees, T., and Shaw, D. (2021, January 13\u201315). PROMPt - point of care testing for hepatitis C in the priority settings of mental health, prisons and drug & alcohol facilities. Proceedings of the International Conference on Hepatitis Care in Substance Users, Virtual."},{"key":"ref_8","unstructured":"MacIsaac, M., Whitton, B., Anderson, J., Cogger, S., Elmore, K., Pemberton, D., Penn, M., Holmes, J., Clark, N., and Thompson, A. (2021, January 13\u201315). Rapid point of care HCV testing allows high throughout HCV screening and rapid treatment uptake among PWID attending a medically supervised injecting room. Proceedings of the International Conference on Hepatitis Care in Substance Users, Virtual."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Saludes, V., Antuori, A., Lazarus, J., Folch, C., Gonz\u00e1lez-G\u00f3mez, S., Gonz\u00e1lez, N., Ib\u00e1\u00f1ez, N., Colom, J., Matas, L., and Casabona, J. (2020). Evaluation of the Xpert HCV VL Fingerstick point-of-care assay and dried blood spot HCV-RNA testing as simplified diagnostic strategies among people who inject drugs in Catalonia, Spain. Int. J. Drug Policy, 80.","DOI":"10.1016\/j.drugpo.2020.102734"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Ryan, P., Valencia, J., Cuevas, G., Torres-Macho, J., Troya, J., Pueyo, \u00c1., Mu\u00f1oz-G\u00f3mez, M.J., Mu\u00f1oz-Rivas, N., V\u00e1zquez-Mor\u00f3n, S., and Martinez, I. (2021). Detection of active hepatitis C in a single visit and linkage to care among marginalized people using a mobile unit in Madrid, Spain. Int. J. Drug Policy, 96.","DOI":"10.1016\/j.drugpo.2021.103424"},{"key":"ref_11","unstructured":"Sheehan, Y., Cunningham, E.B., Cochrane, A., Byrne, M., Brown, T., McGrath, C., Lafferty, L., Tedla, N., Lloyd, A.R., and Grebley, J. (2021, January 13\u201315). A \u2018one-stop-shop\u2019 intervention integrating point-of-care HCV RNA testing to enhance hepatitis C testing and treatment uptake among new receptions to prison: The PIVOT Study. Proceedings of the International Network on Health and Hepatitis in Substance Users Conference, Virtual."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.drugpo.2017.07.002","article-title":"Interventions to enhance testing, linkage to care and treatment uptake for hepatitis C virus infection among people who inject drugs: A systematic review","volume":"47","author":"Bajis","year":"2017","journal-title":"Int. J. Drug Policy"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/jvh.13487","article-title":"Hepatitis C treatment in a co-located mental health and alcohol and drug service using a nurse-led model of care","volume":"28","author":"Harney","year":"2021","journal-title":"J. Viral Hepat."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1093\/cid\/ciaa111","article-title":"Co-located opioid use disorder and Hepatitis C virus treatment is not only right, but it is also the smart thing to do as it improves outcomes!","volume":"71","author":"Springer","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1001\/jamainternmed.2022.0170","article-title":"Accessible Hepatitis C Care for People Who Inject Drugs: A Randomized Clinical Trial","volume":"182","author":"Eckhardt","year":"2022","journal-title":"JAMA Intern. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/jvh.13664","article-title":"The impact of point-of-care hepatitis C testing in needle and syringe exchange programs on linkage to care and treatment uptake among people who inject drugs: An Australian pilot study","volume":"29","author":"Howell","year":"2022","journal-title":"J. Viral Hepat."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.drugpo.2019.05.012","article-title":"Point-of-care hepatitis C testing from needle and syringe programs: An Australian feasibility study","volume":"72","author":"Williams","year":"2019","journal-title":"Int. J. Drug Policy"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1093\/infdis\/jiac049","article-title":"Diagnostic Accuracy of Assays Using Point-of-Care Testing or Dried Blood Spot Samples for the Determination of Hepatitis C Virus RNA: A Systematic Review","volume":"226","author":"Catlett","year":"2022","journal-title":"J. Infect. Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1111\/dar.13282","article-title":"Concordance between self-reported and current hepatitis C virus infection status in a sample of people who inject drugs in Sydney and Canberra, Australia","volume":"40","author":"Gibbs","year":"2021","journal-title":"Drug Alcohol. Rev."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1080\/23744235.2017.1334263","article-title":"Prevalence of hepatitis C and pre-testing awareness of hepatitis C status in 1500 consecutive PWID participants at the Stockholm needle exchange program","volume":"49","author":"Hammarberg","year":"2017","journal-title":"Infect. Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s41124-016-0016-6","article-title":"Concordance between self-reported and measured HIV and hepatitis C virus infection status among people who inject drugs in Germany","volume":"1","author":"Nielsen","year":"2016","journal-title":"Hepatol. Med. Policy"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Valerio, H., Conway, A., Alavi, M., Treloar, C., Silk, D., Murray, C., Henderson, C., Amin, J., Read, P., and Degenhardt, L. (2022). Awareness of hepatitis C virus infection status among people who inject drugs in a setting of universal direct-acting antiviral therapy: The ETHOS Engage study. Int. J. Drug Policy, 110.","DOI":"10.1016\/j.drugpo.2022.103876"},{"key":"ref_23","first-page":"208","article-title":"Concordance between self-reported and actual hepatitis C virus infection status in a cohort of people who inject drugs","volume":"32","author":"Aitken","year":"2012","journal-title":"Drug Alcohol. Rev."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Marshall, A., Rance, J., Grebely, J., and Treloar, C. (2022). \u2018Not just one box that you tick off\u2019\u2014Deconstructing the hepatitis C care cascade in the interferon-free direct acting antiviral era from the client perspective. Int. J. Drug Policy, 102.","DOI":"10.1016\/j.drugpo.2022.103610"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Carson, J.M., Hajarizadeh, B., Hanson, J., O\u2019Beirne, J., Iser, D., Read, P., Balcomb, A., Davies, J., Doyle, J.S., and Yee, J. (2021). Effectiveness of treatment for hepatitis C virus reinfection following direct acting antiviral therapy in the REACH-C cohort. Int. J. Drug Policy, 96.","DOI":"10.1016\/j.drugpo.2021.103422"},{"key":"ref_26","unstructured":"Heard, S., Iversen, J., and Maher, L. (2021). Australian NSP Survey National Data Report 2016\u20132020: Prevalence of HIV, HCV and Injecting and Sexual Behaviour among NSP Attendees, Kirby Institute, UNSW Sydney."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Radley, A., Robinson, E., Aspinall, E.J., Angus, K., Tan, L., and Dillon, J. (2019). A systematic review and meta-analysis of community and primary-care-based hepatitis C testing and treatment services that employ direct acting antiviral drug treatments. BMC Health Serv. Res., 19.","DOI":"10.1186\/s12913-019-4635-7"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.drugalcdep.2013.07.023","article-title":"Client and staff experiences of a co-located service for hepatitis C care in opioid substitution treatment settings in New South Wales, Australia","volume":"133","author":"Treloar","year":"2013","journal-title":"Drug Alcohol Depend."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12954-019-0330-6","article-title":"Injecting-related health harms and overuse of acidifiers among people who inject heroin and crack cocaine in London: A mixed-methods study","volume":"16","author":"Harris","year":"2019","journal-title":"Harm Reduct. J."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.2105\/AJPH.2011.300251","article-title":"Public Health Implications of Rapid Hepatitis C Screening With an Oral Swab for Community-Based Organizations Serving High-Risk Populations","volume":"101","author":"Drobnik","year":"2011","journal-title":"Am. J. Public Health"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S2468-1253(21)00471-4","article-title":"Interventions to enhance testing and linkage to treatment for hepatitis C infection: A systematic review and meta-analysis","volume":"7","author":"Cunningham","year":"2021","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_32","unstructured":"Sutherland, R., Karlsson, A., King, C., Jones, F., Uporova, J., Price, O., Gibbs, D., Bruno, R., Dietze, P., and Lenton, S.R. (2022). Australian Drug Trends 2022: Key Findings from the National Illicit Drug Reporting System (IDRS) Interviews, NDARC. Available online: http:\/\/handle.unsw.edu.au\/1959.4\/unsworks_81243."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/14\/11\/2463\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:11:58Z","timestamp":1760145118000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/14\/11\/2463"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,7]]},"references-count":32,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022,11]]}},"alternative-id":["v14112463"],"URL":"https:\/\/doi.org\/10.3390\/v14112463","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,7]]}}}